Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 1, 2010

Primary Completion Date

August 1, 2011

Study Completion Date

August 1, 2011

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Paracetamol

665 mg sustained release paracetamol caplets

DRUG

Placebo

Placebo caplets

Trial Locations (1)

CP: 08003

Hospital Del Mar, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY